MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
345.60%
Quick Ratio
337.66%
Cash Ratio
77.76%
Debt to Asset Ratio
26.08%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Non-current marketable securitie...
    • Trade receivables, net
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Non-current operating lease liab...
    • Others
Balance Sheets
2026-07-03
2026-04-03
2026-01-02
2025-10-03
Cash and cash equivalents
281,448
226,152
482,488
376,300
Marketable securities
557,937
551,055
576,603
612,235
Trade receivables, net
322,213
328,947
286,916
309,725
Inventory
28,729
26,605
21,686
27,402
Prepaid expenses and other current assets
60,495
75,878
75,596
76,595
Total current assets
1,250,822
1,208,637
1,443,289
1,402,257
Non-current marketable securities
544,930
649,144
603,603
578,287
Property and equipment, net
92,665
95,524
98,960
104,748
Deferred tax assets, net
294,205
293,730
292,582
418,582
Goodwill
63,684
63,684
63,684
63,684
Right-of-use assets and other non-current assets
247,928
282,874
342,305
255,989
Total assets
2,494,234
2,593,593
2,844,423
2,823,547
Accounts payable
39,062
24,154
29,623
25,348
Accrued compensation and benefits
68,629
87,512
102,218
104,364
Accrued clinical trial liabilities
59,767
64,804
65,742
57,781
Rebates and fees due to customers
66,711
65,892
59,896
58,234
Accrued collaboration liabilities
25,096
28,327
22,783
23,428
Other current liabilities
102,662
100,286
125,382
104,622
Total current liabilities
361,927
370,975
405,644
373,777
Non-current operating lease liabilities
165,929
169,541
173,038
176,463
Other non-current liabilities
122,616
117,329
104,422
112,607
Total liabilities
650,472
657,845
683,104
662,847
Common stock, 0.001 par value 400,000 shares authorized issued and outstanding 248,885 and 262,483 at june 30, 2026, and december 31, 2025, respectively
249
254
262
268
Additional paid-in-capital
2,108,059
2,151,703
2,234,411
2,262,928
Accumulated other comprehensive income (loss)
-2,013
-415
3,476
3,565
Accumulated deficit
-262,533
-215,794
-76,830
-106,061
Total stockholders equity
1,843,762
1,935,748
2,161,319
2,160,700
Total liabilities and stockholders equity
2,494,234
2,593,593
2,844,423
2,823,547
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$557,937K (-10.97%↓ Y/Y)Trade receivables,net$322,213K (10.21%↑ Y/Y)Cash and cashequivalents$281,448K (71.16%↑ Y/Y)Prepaid expenses andother current assets$60,495K (-18.06%↓ Y/Y)Inventory$28,729K (22.34%↑ Y/Y)Total current assets$1,250,822K (5.93%↑ Y/Y)Non-current marketablesecurities$544,930K (-8.36%↓ Y/Y)Deferred tax assets, net$294,205K (-29.82%↓ Y/Y)Right-of-use assets and othernon-current assets$247,928K (-19.87%↓ Y/Y)Property and equipment,net$92,665K (-16.00%↓ Y/Y)Goodwill$63,684K (0.00%↑ Y/Y)Total assets$2,494,234K (-6.86%↓ Y/Y)Total liabilities andstockholders equity$2,494,234K (-6.86%↓ Y/Y)Total stockholdersequity$1,843,762K (-9.33%↓ Y/Y)Total liabilities$650,472K (0.92%↑ Y/Y)Accumulated deficit-$262,533K (-19.58%↓ Y/Y)Accumulated othercomprehensive income (loss)-$2,013K (-249.22%↓ Y/Y)Additionalpaid-in-capital$2,108,059K (-6.37%↓ Y/Y)Total currentliabilities$361,927K (7.68%↑ Y/Y)Non-current operating leaseliabilities$165,929K (-7.74%↓ Y/Y)Other non-currentliabilities$122,616K (-4.65%↓ Y/Y)Common stock, 0.001 parvalue 400,000 shares...$249K (-7.78%↓ Y/Y)Other currentliabilities$102,662K (1.28%↑ Y/Y)Accrued compensationand benefits$68,629K (-5.01%↓ Y/Y)Rebates and fees due tocustomers$66,711K (16.47%↑ Y/Y)Accrued clinical trialliabilities$59,767K (3.27%↑ Y/Y)Accounts payable$39,062K (51.28%↑ Y/Y)Accrued collaborationliabilities$25,096K (16.59%↑ Y/Y)
Exelixis-Logo-2023-svg

EXELIXIS, INC. (EXEL)

Exelixis-Logo-2023-svg

EXELIXIS, INC. (EXEL)